VOR - Vor Biopharma Inc.

QQQ $ 437.83 $ 0.87 (0.2 %)

DIA $ 388.05 $ -0.42 (-0.11 %)

SPY $ 514.35 $ 0.57 (0.11 %)

TLT $ 89.81 $ -0.07 (-0.08 %)

GLD $ 215.16 $ 0.13 (0.06 %)

Previous Close

$ 1.8

Open

$ 1.78

Bid

$ 0.00 x 0

Ask

$ 1.78 x 200

Day's Range

$ 1.77 - $ 1.78

52 Week Range

$ 1.62 - $ 5.70

Volume

162,062

Average Volume

Market Cap

120.95M

Beta (5Y Monthly)

$ 0.58

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	03-20-2024	12-31-2023	10-K
2	11-07-2023	09-30-2023	10-Q
3	08-10-2023	06-30-2023	10-Q
4	05-11-2023	03-31-2023	10-Q
5	03-23-2023	12-31-2022	10-K
6	11-10-2022	09-30-2022	10-Q
7	08-11-2022	06-30-2022	10-Q
8	05-12-2022	03-31-2022	10-Q
9	03-14-2022	12-31-2021	10-K
10	11-10-2021	09-30-2021	10-Q
11	08-09-2021	06-30-2021	10-Q
12	05-06-2021	03-31-2021	10-Q
13	03-25-2021	12-31-2020	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Wedbush Reiterates Outperform on Vor Bioph...
04/23/2024 17:24:12

Wedbush analyst David Nierengarten reiterates Vor Biopharma (NASDAQ:VOR) with a Outperform and maintains $11 price target.

12-health-care-stocks-moving-in-fridays-after-market-session

12 Health Care Stocks Moving In Friday's A...
04/05/2024 20:31:09

JMP Securities Reiterates Market Outperfor...
03/22/2024 17:13:57

JMP Securities analyst Silvan Tuerkcan reiterates Vor Biopharma (NASDAQ:VOR) with a Market Outperform and maintains $12 pric...

Stifel Maintains Buy on Vor Biopharma, Low...
03/21/2024 13:39:11

Stifel analyst Stephen Willey maintains Vor Biopharma (NASDAQ:VOR) with a Buy and lowers the price target from $15 to $12.

Wedbush Reiterates Outperform on Vor Bioph...
03/21/2024 13:14:24

Wedbush analyst David Nierengarten reiterates Vor Biopharma (NASDAQ:VOR) with a Outperform and maintains $11 price target.

Oppenheimer Reiterates Outperform on Vor B...
03/21/2024 13:02:18

Oppenheimer analyst Matthew Biegler reiterates Vor Biopharma (NASDAQ:VOR) with a Outperform and lowers the price target from...

HC Wainwright & Co. Reiterates Buy on Vor ...
03/21/2024 10:44:06

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Vor Biopharma (NASDAQ:VOR) with a Buy and maintains $17.5 ...

Vor Biopharma: Q4 Earnings Insights
03/20/2024 21:30:17

Vor Biopharma Expects To Report Further En...
03/20/2024 20:34:12

Vor Biopharma Q4 2023 GAAP EPS $(0.39) Bea...
03/20/2024 20:30:12

Vor Biopharma (NASDAQ:VOR) reported quarterly losses of $(0.39) per share which beat the analyst consensus estimate of $(0.51) ...

Wedbush Reiterates Outperform on Vor Bioph...
01/18/2024 13:24:37

Wedbush analyst David Nierengarten reiterates Vor Biopharma (NASDAQ:VOR) with a Outperform and maintains $11 price target.

Vor Bio Doses First AML Patient With VCAR33
01/17/2024 21:02:05

Vor Bio Presents Data Update On Trem-cel A...
11/09/2023 21:49:25

Primary neutrophil engraftment of trem-cel achieved in all seven patients treated to date All three patients receiving multiple...

Vor Biopharma Q3 EPS $(0.49) Misses $(0.47...
11/07/2023 22:17:27

Vor Biopharma (NASDAQ:VOR) reported quarterly losses of $(0.49) per share which missed the analyst consensus estimate of $(0.47...

Multiple Clinical And Preclinical Presenta...
11/02/2023 13:20:59

Three oral and two poster presentations accepted by ASH Company to host call featuring Sarah K. Tasian, MD, Associate Professor...

Stocks That Hit 52-Week Lows On Tuesday
10/03/2023 18:37:58

On Tuesday, 647 companies set new 52-week lows.

Stocks That Hit 52-Week Lows On Thursday
09/21/2023 16:08:37

During the session on Thursday, 461 stocks hit new 52-week lows.

Stocks That Hit 52-Week Lows On Tuesday
09/19/2023 16:50:48

During Tuesday's session, 275 companies made new 52-week lows.

The Latest Analyst Ratings for Vor Biopharma
08/14/2023 16:00:49

JMP Securities Reiterates Market Outperfor...
08/14/2023 12:52:03

JMP Securities analyst Silvan Tuerkcan reiterates Vor Biopharma (NASDAQ:VOR) with a Market Outperform and maintains $12 pric...